Skip to content

MOTION MEDICAL: what changed

BE 0690.810.739NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€105,922
2024 · €323,163-€217,241
Equity
€3.7m
2024 · €3.6m+€105,922
Cash
€131,240
2024 · €105,453+€25,786
Balance sheet total
€7.1m
2024 · €7.6m-€560,313

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€622,108

    down €622,108 (-12.0%), from €5.2m to €4.6m

    of which Trade receivables: -€728,946

Equity and liabilities
  • Trade debts -€403,241

    down €403,241 (-16.6%), from €2.4m to €2.0m

  • Current portion of long-term debt -€221,879

    down €221,879 (-92.2%), from €240,655 to €18,776

  • Profit (loss) carried forward +€105,922

    up €105,922 (+4.2%), from €2.5m to €2.6m

Income statement
  • Gross operating margin -€437,208

    down €437,208 (-35.6%), from €1.2m to €792,178

  • Write-downs -€294,575

    down €294,575, from €277,361 to -€17,214

  • Financial income +€67,240

    up €67,240 (+13,856%), from €485 to €67,725

  • Staff costs +€41,168

    up €41,168 (+8.8%), from €469,708 to €510,876

  • Depreciation +€38,347

    up €38,347 (+49.0%), from €78,190 to €116,537

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €323,163
Gross operating margin -€437,208
Staff costs -€41,168
Depreciation -€38,347
Write-downs +€294,575
Other operating charges -€2,211
Other operating items -€49,304
Financial income +€67,240
Financial charges -€12,129
Taxes +€1,309
Result 2025 €105,922
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€417,208
Investment -€154,295
Financing -€237,127
Cash 2024 €105,453
Net result for the year +€105,922
Depreciation +€116,537
Stocks and contracts +€51,642
Receivables within one year +€622,108
Deferred charges and accrued income -€49,893
Trade debts -€403,241
Tax, wage and social debts +€16,654
Accrued charges and deferred income -€42,521
Investment in fixed assets (net) -€154,295
Debts after one year -€23,088
Current portion of long-term debt -€221,879
Short-term financial debts +€7,840
Cash 2025 €131,240
brings cash intakes cash out
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €7,647,705 €7,087,392 -€560,313 -7.3%
Fixed assets 21/28 €394,615 €432,374 +€37,759 +9.6%
Intangible fixed assets 21 €20,577 €26,931 +€6,353 +30.9%
Tangible fixed assets 22/27 €120,613 €152,269 +€31,655 +26.2%
Land and buildings 22 €1,418 €1,077 -€341 -24.0%
Plant, machinery and equipment 23 €90,737 €129,590 +€38,853 +42.8%
Furniture and vehicles 24 €25,216 €19,481 -€5,735 -22.7%
Other tangible fixed assets 26 €3,243 €2,121 -€1,122 -34.6%
Financial fixed assets 28 €253,424 €253,174 -€250 -0.1%
Current assets 29/58 €7,253,090 €6,655,018 -€598,071 -8.2%
Stocks and contracts in progress 3 €1,930,432 €1,878,790 -€51,642 -2.7%
Stocks 30/36 €1,930,432 €1,878,790 -€51,642 -2.7%
Amounts receivable within one year 40/41 €5,200,601 €4,578,492 -€622,108 -12.0%
Trade receivables 40 €2,340,725 €1,611,779 -€728,946 -31.1%
Other amounts receivable 41 €2,859,876 €2,966,713 +€106,838 +3.7%
Cash at bank and in hand 54/58 €105,453 €131,240 +€25,786 +24.5%
Deferred charges and accrued income 490/1 €16,603 €66,497 +€49,893 +301%
Total equity and liabilities 10/49 €7,647,705 €7,087,392 -€560,313 -7.3%
Equity 10/15 €3,589,294 €3,695,216 +€105,922 +3.0%
Contributions 10/11 €1,003,121 €1,003,121 = 0.0%
Reserves 13 €52,624 €52,624 = 0.0%
Distributable reserves 133 €52,624 €52,624 = 0.0%
Profit (loss) carried forward 14 €2,533,549 €2,639,471 +€105,922 +4.2%
Amounts payable 17/49 €4,058,411 €3,392,176 -€666,234 -16.4%
Amounts payable after more than one year 17 €550,067 €526,979 -€23,088 -4.2%
Financial debts 170/4 €550,067 €526,979 -€23,088 -4.2%
Amounts payable within one year 42/48 €3,465,822 €2,865,197 -€600,625 -17.3%
Current portion of amounts payable after more than one year 42 €240,655 €18,776 -€221,879 -92.2%
Financial debts 43 €661,282 €669,123 +€7,840 +1.2%
Credit institutions 430/8 €661,282 €669,123 +€7,840 +1.2%
Trade debts 44 €2,432,831 €2,029,590 -€403,241 -16.6%
Suppliers 440/4 €2,432,831 €2,029,590 -€403,241 -16.6%
Taxes, remuneration and social security 45 €131,054 €147,709 +€16,654 +12.7%
Taxes 450/3 €69,396 €34,633 -€34,762 -50.1%
Remuneration and social security 454/9 €61,659 €113,075 +€51,417 +83.4%
Accrued charges and deferred income 492/3 €42,521 €0 -€42,521 -100%
Remuneration, social security and pensions 62 €469,708 €510,876 +€41,168 +8.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €78,190 €116,537 +€38,347 +49.0%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €277,361 -€17,214 -€294,575
Other operating charges 640/8 €30 €2,241 +€2,211 +7,369%
Non-recurring operating charges 66A - €49,304 +€49,304
Gross operating margin 9900 €1,229,386 €792,178 -€437,208 -35.6%
Operating profit (loss) 9901 €404,096 €130,435 -€273,661 -67.7%
Financial income 75/76B €485 €67,725 +€67,240 +13,856%
Recurring financial income 75 €485 €67,725 +€67,240 +13,856%
Financial charges 65/66B €44,803 €56,931 +€12,129 +27.1%
Recurring financial charges 65 €44,803 €56,931 +€12,129 +27.1%
Profit (loss) for the period before taxes 9903 €359,779 €141,229 -€218,550 -60.7%
Income taxes 67/77 €36,616 €35,307 -€1,309 -3.6%
Profit (loss) for the period 9904 €323,163 €105,922 -€217,241 -67.2%
Profit (loss) for the period to be appropriated 9905 €323,163 €105,922 -€217,241 -67.2%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€2.1m to €2.2m

Midpoint €2.1m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €3.7m
Capitalised earnings €507,171 to €710,040
Indication €2.1m to €2.2m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€3,695,216
Intangible fixed assets (21)
-€26,931
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€3.7m

Capitalised earnings

net result for the year (9904)
2025
€105,922
excluding non-recurring income and charges
€155,226
2024
€323,163
2023
-€265,376
2022
€744,027
excluding non-recurring income and charges
€790,384
2021
€1,126,364
excluding non-recurring income and charges
€1,121,319
Average result, excluding non-recurring income and charges
€71,004
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€507,171 / €591,700 / €710,040

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 10 November 2026 via checked.be.